Opsens (TSX:OPS) Risk Assessment

View and export this data going back to 2006. Start your Free Trial

What is Opsens Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Opsens is: No Data: Cannot be evaluated.

Competitive Comparison of Opsens's Risk Assessment

For the Medical Instruments & Supplies subindustry, Opsens's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Opsens's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Opsens's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Opsens's Risk Assessment falls into.

Opsens (TSX:OPS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Opsens Risk Assessment Related Terms

Thank you for viewing the detailed overview of Opsens's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Opsens (TSX:OPS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Opsens Inc (TSX:OPS) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

750, Boulevard du Parc-Technologique, Quebec, QC, CAN, G1P 4S3

Website

https://www.opsens.com

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. It operates in two segments that are Medical and Industrial. In Medical segment it supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices. Industrial segment includes developing, manufacturing and installing fibre optic sensing solutions for industrial applications. Majority of its revenue is derived from Medical segment.

Executives

Alan Milinazzo	Director
Robin Villeneuve	Senior Officer
Fiera Capital Corporation (formerly Fiera Sceptre Inc.)	10% Security Holder

Opsens (TSX:OPS) Headlines

No Headlines